Joslin has developed a number of Clinical Guidelines to help healthcare providers, both at Joslin and in the community, improve the treatment and care of individuals with diabetes. These Guidelines, which are recommendations for clinical practice and treatment, were developed by experts from Joslin Diabetes Center, the world’s leading institution in diabetes research and treatment. They are unique in that they are clear, concise, and easy to use.
The primary objective of Joslin Diabetes Center’s Clinical Guidelines is to support clinical practice and influence clinical behaviors of providers so that outcomes are improved and patient expectations are informed and reasonable. They serve as the basis for all of Joslin’s clinical programs, care pathways, professional and patient education programs and self-management enduring materials at Joslin in Boston, at our Affiliates across the country, and in our outreach programs worldwide.
Joslin’s Clinical Guidelines are established after careful review of current medical literature and sound clinical practice, and then reviewed and approved by Joslin’s Clinical Oversight Committee. This Committee is chaired by the Director of Disease Management, and reports to Joslin Diabetes Center’s Chief Medical Officer.
Joslin Diabetes Center currently has seven approved Guidelines:
- Clinical Guideline for Adults with Diabetes
- Clinical Guideline for the Pharmacological Management of Type 2 Diabetes
- Clinical Nutrition Guideline for Overweight and Obese Adults with Type 2 Diabetes and Pre-diabetes
- Guideline for Specialty Consultation/Referral
- Guideline for Detection and Management of Diabetes in Pregnancy
- Guideline for Management of Hyperglycemic Emergencies for Adults
- Considerations in the Use of Continuous Glucose Monitors
Currently in development:
- Guideline for the Detection and Management of the Metabolic Syndrome
The process Joslin has developed to write, review and revise these Guidelines has been valuable to the Joslin Diabetes Center because it encourages free discussion of evidence in research and clinical practice and it draws upon the diverse expertise of Joslin’s clinicians, researchers and educators.
Our Clinical Guidelines are posted on the Joslin website for individual use, are available through Joslin’s Disease Management web-based Risk Stratification Systems and are distributed to attendees of Joslin’s Professional Education seminars.
NOTICE: Joslin's Clinical Guidelines are reviewed at least annually but are revised as current evidence and clinical practice require. Please check back frequently to ensure that you have the most recent version of each Guideline.
Page last updated: January 20, 2017